High-affinity insulin receptor binding activity was demonstrated on the cell surface in 1972 (9), and in 1975 blockade of receptor binding by autoantibodies to the insulin receptor was shown to cause extreme insulin resistance in rare human patients, further establishing the essential role of these receptors (10). This evidence concerns the gene INSR and Insulin resistance.